{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-052918","form_type":"8-K","ticker":"VRNO","cik":"0001848416","company_name":"Verano Holdings Corp.","filed_at":"2026-08-05T11:13:38+00:00","discovered_at":"2026-08-05T11:15:00.352930+00:00","generated_at":"2026-08-05T11:15:06.893737+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Verano Q2 revenue $218M (+8% YoY), net loss narrows to $13M, adj. EBITDA $51M","bullets":["Revenue $218M, up 5% QoQ and 8% YoY; gross profit $100M (46% of revenue).","Net loss $(13)M improved from $(19)M in Q2 2025; adjusted EBITDA $51M (24% of revenue).","Operating cash flow $31M, up from $11M in Q2 2025; capex guidance tightened to $40-50M for 2026.","Cash $85M, total debt $393M; working capital $295M; 163 dispensaries across 13 states.","Completed 1-for-5 reverse stock split; $20M stock repurchase authorization announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-052918","json":"https://secwatch.observer/filing/0001628280-26-052918.json","markdown":"https://secwatch.observer/filing/0001628280-26-052918.md","text":"https://secwatch.observer/filing/0001628280-26-052918.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1848416/000162828026052918/0001628280-26-052918-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1848416/000162828026052918/vrnof-20260805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T11:15:06.893737+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}